SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation reduction trial aims to ease side effects for head and neck cancer patients
Disease control Recruiting nowThis study tests whether giving less radiation after surgery for certain head and neck cancers can reduce long-term side effects like trouble swallowing, without increasing the chance of cancer coming back. About 508 adults who have had surgery and need standard post-operative ra…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Phase: PHASE2, PHASE3 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
Blood test may allow safer radiation for head and neck cancer
Disease control Recruiting nowThis study is for people with a type of head and neck cancer linked to HPV. Researchers want to see if using a blood test to track cancer DNA can safely allow a lower dose of radiation to the neck. The goal is to keep the cancer under control while reducing side effects. About 90…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Tailored therapy aims to cut side effects in throat cancer patients
Disease control Recruiting nowThis study tests whether giving a personalized, less intense treatment plan to people with early-stage HPV-related throat cancer can keep the cancer from coming back while reducing side effects. About 150 participants will either have surgery followed by observation or limited ra…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC